Loading...

COEP COEPTIS THERAPEUTICS HOLDINGS INC Management Changes 8-K Filing

CPTS

CP

COEPTIS THERAPEUTICS HOLDINGS INC

(COEP)

2025 8-K

Show Summary

Show Summary

Merger of Equals

Management Change

Capital Structure Update

Nasdaq Compliance

Annual Meeting Results

Asset Acquisition

Acquisition Intent

Equity Purchase Agreement

Accountant Change

Nasdaq Compliance

Financial Restatement

Equity Sale and CEO Options...

Financial Restatement

Delisting Notice

Annual Meeting of Stockholders

Securities Purchase Agreement

Investment in Common Stock

Licensing Agreement and Ass...

Underwriting Agreement for ...

Presentation to Investors

Management Changes

Research Agreement with Uni...

External Links:

Colleen Delaney resigned as Chief Scientific and Medical Officer effective March 24, 2025, to pursue another opportunity but will consult for six months.

AI Assistant

COEPTIS THERAPEUTICS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.